[2S09e] Cutting-edge medical innovation based on RNA chemical modification

5:30 PM - 5:45 PM JST(8:30 AM - 8:45 AM UTC)

[2S09e-05] Programmable in vivo CAR-T therapy via epitranscriptomic modification and tunable lipid nanoparticles

^○Sikun Meng¹, Tomoaki Hara¹, Yoshiko Saito¹, Yutaka Miura², Hideshi Ishii¹ (1.Department of Medical Data Science, Center of Medical Innovation and Translational Research, Osaka University Graduate School of Medicine, 2.Laboratory for Chemistry and Life Science, Institute of Integrated Research, Institute of Science Tokyo)

キーテクノロジー：in vivo CAR-T immunotherapy

Keywords:

in vivo CAR-T immunotherapy,epitranscriptomic engineering,lipid nanoparticle

Password required to view